Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4703
Gene Symbol: NEB
NEB
0.120 GeneticVariation phenotype BEFREE Since the patients are characterized by generalized muscle weakness together with neurodevelopmental phenotypes, it is suggested that NEB mutations could manifest more diverse phenotypes than those previously described. 25296583 2014
Entrez Id: 4703
Gene Symbol: NEB
NEB
0.120 GeneticVariation phenotype BEFREE Recessive nebulin (NEB) mutations are a common cause of nemaline myopathy (NM), typically characterized by generalized weakness of early-onset and nemaline rods on muscle biopsy. 23443021 2013
Entrez Id: 4703
Gene Symbol: NEB
NEB
0.120 Biomarker phenotype HPO
Entrez Id: 6607
Gene Symbol: SMN2
SMN2
0.110 Biomarker phenotype BEFREE This disease is characterized by generalized muscle weakness and atrophy predominating in proximal limb muscles, and phenotype is classified into four grades of severity (SMA I, SMAII, SMAIII, SMA IV) based on age of onset and motor function achieved. 22047105 2011
Entrez Id: 6606
Gene Symbol: SMN1
SMN1
0.110 Biomarker phenotype BEFREE This disease is characterized by generalized muscle weakness and atrophy predominating in proximal limb muscles, and phenotype is classified into four grades of severity (SMA I, SMAII, SMAIII, SMA IV) based on age of onset and motor function achieved. 22047105 2011
Entrez Id: 4534
Gene Symbol: MTM1
MTM1
0.110 GeneticVariation phenotype BEFREE The X-linked neonatal form (XLCNM) is due to mutations in MTM1 and involves a severe and generalized muscle weakness at birth. 21129173 2010
Entrez Id: 6261
Gene Symbol: RYR1
RYR1
0.110 AlteredExpression phenotype BEFREE Protein expression studies in nine cases suggested a correlation between specific mutations, RyR1 protein levels and resulting phenotype: in particular, whilst patients with dominant or recessive mutations associated with typical CCD phenotypes appeared to have normal RyR1 expression, individuals with more generalized weakness, multi-minicores and external ophthalmoplegia had a pronounced depletion of the RyR1 protein. 17483490 2007
Entrez Id: 6607
Gene Symbol: SMN2
SMN2
0.110 GeneticVariation phenotype CLINVAR
Entrez Id: 6606
Gene Symbol: SMN1
SMN1
0.110 GeneticVariation phenotype CLINVAR
Entrez Id: 6261
Gene Symbol: RYR1
RYR1
0.110 Biomarker phenotype HPO
Entrez Id: 4534
Gene Symbol: MTM1
MTM1
0.110 Biomarker phenotype HPO
Entrez Id: 8878
Gene Symbol: SQSTM1
SQSTM1
0.100 Biomarker phenotype HPO
Entrez Id: 1610
Gene Symbol: DAO
DAO
0.100 Biomarker phenotype HPO
Entrez Id: 7415
Gene Symbol: VCP
VCP
0.100 Biomarker phenotype HPO
Entrez Id: 29940
Gene Symbol: DSE
DSE
0.100 Biomarker phenotype HPO
Entrez Id: 57505
Gene Symbol: AARS2
AARS2
0.100 Biomarker phenotype HPO
Entrez Id: 4744
Gene Symbol: NEFH
NEFH
0.100 Biomarker phenotype HPO
Entrez Id: 23025
Gene Symbol: UNC13A
UNC13A
0.100 Biomarker phenotype HPO
Entrez Id: 291
Gene Symbol: SLC25A4
SLC25A4
0.100 Biomarker phenotype HPO
Entrez Id: 1293
Gene Symbol: COL6A3
COL6A3
0.100 Biomarker phenotype HPO
Entrez Id: 1305
Gene Symbol: COL13A1
COL13A1
0.100 Biomarker phenotype HPO
Entrez Id: 29954
Gene Symbol: POMT2
POMT2
0.100 Biomarker phenotype HPO
Entrez Id: 4620
Gene Symbol: MYH2
MYH2
0.100 Biomarker phenotype HPO
Entrez Id: 1134
Gene Symbol: CHRNA1
CHRNA1
0.100 Biomarker phenotype HPO
Entrez Id: 2733
Gene Symbol: GLE1
GLE1
0.100 Biomarker phenotype HPO